Editorial & Opinion
Donor specific antibodies (DSA): the only risk factor for primary graft failure?
| العنوان: | Donor specific antibodies (DSA): the only risk factor for primary graft failure? |
|---|---|
| المؤلفون: | Bacigalupo A; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy. andrea.bacigalupo@unicatt.it.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Roma, Italy. andrea.bacigalupo@unicatt.it. |
| المصدر: | Bone marrow transplantation [Bone Marrow Transplant] 2024 Mar; Vol. 59 (3), pp. 299-300. Date of Electronic Publication: 2024 Jan 10. |
| نوع المنشور: | Editorial |
| اللغة: | English |
| بيانات الدورية: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2003->: London : Nature Publishing Group Original Publication: Basingstoke, Hampshire : Scientific & Medical Division, Macmillan Press, c1986- |
| مواضيع طبية MeSH: | Antibodies* , Graft Rejection*, Humans ; Risk Factors ; HLA Antigens ; Graft Survival ; Isoantibodies ; Tissue Donors |
| References: | Altareb M, Al-Awwami M, Feras A, Saud AU, Osman S, Marwan S, et al. Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation: single centre experience. Bone Marrow Transplant. 2023;58:680–6. https://doi.org/10.1038/s41409-023-01950-4 . (PMID: 10.1038/s41409-023-01950-436959370) Valcárcel D, Sureda A. Graft Failure. In: Carreras E, Dufour C, Mohty M, et al. editors. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies. 7th ed. Cham (CH): Springer; 2019. https://doi.org/10.1007/978-3-030-02278-5_41 . Locatelli F, Lucarelli B, Merli P. Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation. Exp Opin Pharmacol. 2014;15:23–36. (PMID: 10.1517/14656566.2014.852537) Spellman S, Bray R, Rosen-Bronson S, Haagenson M, Klein J, Flesch S, et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood. 2010;115:2704–8. (PMID: 10.1182/blood-2009-09-244525200899632852369) Ciurea SO, Thall PF, Milton DR, Barnes TH, Kongtim P, Carmazzi Y, et al. Complement-binding donor-specific anti-HLA antibodies and risk of primary graft failure in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2015;21:1392–8. (PMID: 10.1016/j.bbmt.2015.05.001259859194506716) Ciurea SO, Cao K, Fernandez-Vina M, Kongtim P, Malki MA, Fuchs E, et al. The European Society for Blood and Marrow Transplantation (EBMT) consensus guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in haploidentical hematopoietic cell transplantation. Bone Marrow Transplant. 2018;53:521–34. (PMID: 10.1038/s41409-017-0062-8293356257232774) Bramanti S, Calafiore V, Longhi E, Mariotti J, Crespiatico L, Sarina B, et al. Donor-specific anti-HLA antibodies in haploidentical stem cell transplantation with post-transplantation cyclophosphamide: risk of graft failure, poor graft function, and impact on outcomes. Biol Blood Marrow Transplant. 2019;25:1395–406. (PMID: 10.1016/j.bbmt.2019.02.02030826463) Giammarco S, Raiola AM, Di Grazia C, Bregante S, Gualandi F, Varaldo R, et al. Second haploidentical stem cell transplantation for primary graft failure. Bone Marrow Transplant. 2021;56:1291–6. (PMID: 10.1038/s41409-020-01183-933328569) Patterson J, Prentice HG, Brenner MK, Gilmore M, Janossy G, Ivory K, et al. Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation. Br J Haematol. 1986;63:221–30. (PMID: 10.1111/j.1365-2141.1986.tb05544.x3521712) Storb R, Raff RF, Appelbaum FR, Graham TC, Schuening FG, Sale G, et al. Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts. Blood. 1989;74:1139–43. (PMID: 10.1182/blood.V74.3.1139.11392665864) Solh H, Rao K, Martins da Cunha A, Padmos A, Giri N, Spence D, et al. Engraftment failure following bone marrow transplantation in children with thalassemia major using busulfan and cyclophosphamide conditioning. Pediatr Hematol Oncol. 1997;14:73–7. https://doi.org/10.3109/08880019709030887 . (PMID: 10.3109/088800197090308879021816) Haddad E, Leroy S, Buckley RH. B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment? J Allergy Clin Immunol. 2013;131:994–1000. https://doi.org/10.1016/j.jaci.2013.01.047 . (PMID: 10.1016/j.jaci.2013.01.047234656603615028) |
| المشرفين على المادة: | 0 (Antibodies) 0 (HLA Antigens) 0 (Isoantibodies) |
| تواريخ الأحداث: | Date Created: 20240110 Date Completed: 20240311 Latest Revision: 20240311 |
| رمز التحديث: | 20240311 |
| DOI: | 10.1038/s41409-023-02163-5 |
| PMID: | 38200242 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1476-5365 |
|---|---|
| DOI: | 10.1038/s41409-023-02163-5 |